한국미생물·생명공학회지 (Microbiology and Biotechnology Letters)

  • 제42권2호
  • /
  • Pages.207-210
  • /
  • 2014
  • /
  • 1598-642X(pISSN)
  • /
  • 2234-7305(eISSN)
한국미생물·생명공학회 (The Korean Society for Microbiology and Biotechnology)
권호 표지
DOI QR코드

DOI QR Code

Gallic acid의 Coxsackievirus B3와 Coxsackievirus B4에 대한 항바이러스 효과

Antiviral Activity of Gallic Acid against Coxsackievirus B3 and Coxsackievirus B4

  • 최화정 (광주여자대학교 미용과학과)
  • Choi, Hwa-Jung (Department of Beauty Science, Kwangju Women's University)
  • 투고 : 2014.04.16
  • 심사 : 2014.05.12
  • 발행 : 2014.06.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

바이러스 감염은 감염된 숙주세포에서 활성산소를 유도할 수 있으며, 항산화제들은 많은 바이러스에 대해서 항바이러스 능을 갖는다고 보고되었다. 본 연구에서 cytopathic effect (CPE) reduction 방법에 의한 항바이러스 활성 평가에서 gallic acid는 현저하게 CPE형성을 감소시키면서 coxsackievirus B3 (CB3)와 coxsackievirus B4 (CB4)에 대해 항바이러스 활성을 나타내었다. 그러나 rabavirin은 CB3와 CB4에 대해 CPE를 막지 못하면서 약한 항바이러스 활성을 나타내었다. 그럼으로 gallic acid의 CB3와 CB4에 대한 항바이러스 활성은 항산화제 효능 때문인 것으로 사료된다.

Viral infections are capable of inducing reactive oxygen species (ROS) production in the infected cells and antioxidants have been reported to have antiviral activities against many viruses. In this study, an antiviral assay using the cytopathic effect (CPE) reduction method revealed that gallic acid possesses good anti-coxsackievirus B3 (CB3) and coxsackievirus B4 (CB4) activities, reducing the formation of visible CPE. However, ribavirin did exhibit weak anti-CB3 and CB4 activities and was unable to prevent CPE. Therefore, we conclude that the inhibition of CB3 or CB4 production by gallic acid may be due to its general action as an antioxidant.

키워드

참고문헌

  1. Agol VI, Belov GA, Bienz K, Egger D, Kolesnikova MS, Raikhlin NT, et al. 1998. Two types of death of poliovirus-infected cells: caspase involvement in the apoptosis but not cytopathic effect. Virol. 252: 343-353. https://doi.org/10.1006/viro.1998.9438
  2. Bhatt LR, Yook CN, Choi HJ, Baek SH. 2008. Radical scavenging activity of gallic acid from Woodfordia Fruticosa flowers. Korean J. Oriental Physiol. Pathol. 22: 903-906.
  3. Choi HJ, Kim JH, Lee CH, Ahn YJ, Song JH, Baek SH, et al. 2008. Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus. Antiviral Res. 81: 77-81.
  4. Gaudernak E, Seipelt J, Triendl A, Grassauer A, Kuechler E. 2002. Antiviral effects of pyrrolidine dithiocarbamate on human rhinoviruses. J. Virol. 76: 6004-6015. https://doi.org/10.1128/JVI.76.12.6004-6015.2002
  5. Jason DG, Craig EC. 2006. Mechanisms of action of ribavirin against distinct viruses. Rev. Med. Virol. 16: 37-48. https://doi.org/10.1002/rmv.483
  6. Kaul P, Biagioli MC, SinghI, Turner RB. 2000. Rhinovirus induced oxidative stress and interleukin-8 elaboration involves p47-phox but is independent of attachment to intercellular adhesion molecule-1 and viral replication. J. Infect. Dis. 181: 1885-1890. https://doi.org/10.1086/315504
  7. Kratz JM, Andrighetti-Fröhner CR, Kolling DJ, Leal PC, Cirne- Santos CC, Yunes RA, et al. 2008. Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate. Mem. Inst. Oswaldo Cruz 103: 437-442. https://doi.org/10.1590/S0074-02762008000500005
  8. Weiss L, Hildt E, Hofschneider PH. 1996. Anti-hepatitis B virus activity of N-acetyl-L-cysteine (NAC): new aspects of a wellestablished drug. Antiviral Res. 32: 43-53. https://doi.org/10.1016/0166-3542(95)00977-9